Balancing Acute Graft Versus Host Disease (aGVHD) and Survival after Peripheral Allogeneic Stem Cell Transplantation (SCT) in Hematological Malignancies: A Potential for Graft Engineering.
Ayman Saad(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Michael Craig(Edith Cowan University), Abraham S. Kanate(HonorHealth), Pam Bunner(West Virginia University), Mohammed Almubarak(West Virginia University), Aaron Cumpston(West Virginia University Hospitals), Gerry Hobbs(West Virginia University), Regina Buckhalter(West Virginia University)
Cited by 1
Related Papers
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
|Blood|2016|554
Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy
|Transplantation and Cellular Therapy|2020|278